Replies to post #61 on Affymetrix Inc. (AFFX)

[surf1944]

5:47AM Affymetrix achieves first FDA Clearance of microarray-based gene profiling reagents (AFFX) 6.16 : Co announces that the FDA has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making co the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives.